UNIVERSAL, CITY, CALIF. — UNIVERSAL CITY, Calif. -- Aerosolized pentamizine, used to prevent recurrence of a pneumonia that is a major killer of AIDS patients, appears to be inadequate, according to new studies at the University of Southern California.
Dr. Narsing Rao, director of Ophthalmologic Pathology at the Doheny Eye Institute in Los Angeles, yesterday urged eye exams by physicians every three months for longtime users of aerosolized pentamizine, which is inhaled into the lungs. Rao said the exams are necessary for early detection of signs in the eye that the pneumonia has spread from the lungs to other organs.
"Pneumocystis carinii pneumonia is leaving the lungs and spreading to various parts of the body, just like cancer," he told a science writers' seminar here sponsored by the New York-based Research to Prevent Blindness. "Something else may be involved here. We think a better prophylaxis is needed.